Aging Population & Rising Prevalence of Chronic Illnesses Drive the Clinical Nutrition Products Market, According to a New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Clinical Nutrition Products.The global market for Clinical Nutrition Products is projected to reach US$53.9 billion by 2020, driven by specific nutritional needs of the elderly.

Clinical Nutrition Products: A Global Strategic Business Report

Follow us on LinkedIn – Clinical nutrition is critical for patients who are unable to consume normal food, as nutritional deficiency caused by the underlying disease condition enhances the risk of complications, lengthens recovery period, lowers quality of life, and increases risk of mortality. By providing the required amounts of essential nutrients such as proteins, vitamins and minerals to patients, clinical nutrition products aid in improving metabolism, digestion, absorption, and discharge functions that are critical for normal functioning of the body. These products are vital for patients in intensive care units, patients suffering from chronic illnesses, patients recuperating from trauma and surgeries, and for patients with a high degree of malnourishment. As the risk of complications is higher in malnourished patients, clinical nutrition intervention plays a key role in correcting nutritional imbalances. Malnutrition, if left untreated, could cause a marked decline in physical and psychological health and function, and also impair recovery from disease and injury, or surgery. The treatment of disease-related malnutrition with timely clinical nutrition therapies has been found to reduce mortality and other complications.

Aging population, increasing incidence of chronic and lifestyle-related diseases, and shift towards home care, are major factors driving demand in the market. Rising number of premature births is also spurring demand for medical products that can meet the nutritional needs of infants. The market is also benefiting from sustained investments made by manufacturers as well as government agencies to develop products with improved nutritional attributes. Technological innovations and automation have made it possible to administer clinical nutrition therapies at home without the aid of a trained professional. Also driving growth in the market is the development of lighter and simpler medical devices used for administering enteral and parenteral nutrition therapies, in both adults and children. However, stringent regulatory and reimbursement scenario, need for adequate clinical evidence in support of new ingredients or products, and the need to comply with safety and quality standards are hindering growth in the market.

As stated by the new market research report on Clinical Nutrition Products, the United States represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market with a CAGR of 11.8% over the analysis period. Rising life expectancies, growth in the number of disease specific therapies, heightened awareness about benefits of clinical nutrition, changing lifestyles, better access to healthcare facilities, and increasing shift towards home patient care, represent key growth drivers in the region.

Key players covered in the report include Abbott Nutrition, American HomePatient Inc., Baxter International Inc., B. Braun Melsungen AG, Claris Lifesciences Ltd., Groupe Danone, Nutricia North America, Fresenius Kabi AG, Hospira Inc., Mead Johnson Nutrition Company, Meiji Co. Ltd., Nestlé Health Science S.A, Otsuka Pharmaceutical Factory Inc., and Sino-Swed Pharmaceutical Corp Ltd., among others.

The research report titled “Clinical Nutrition Products: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive analysis of industry segments, trends, growth drivers, market share, market size and demand forecasts, issues, product launches and other strategic industry activities of major companies. Geographic regions and countries analyzed in the report include the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (Australia, China, India, and Rest of Asia-Pacific), Middle East/Africa and Latin America (Brazil, Mexico, and Rest of Latin America). Product segments analyzed include Enteral Nutrition, Infant Nutrition and Parenteral Nutrition.

For more details about this comprehensive market research report, please click here

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site:

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website